PIEZO1 and Alzheimer disease: Although emerging evidence suggests that specific ion channels, such as Piezo1, may contribute to AD pathogenesis via OPC-mediated mechanisms, there is still a lack of reliable preclinical or clinical data evaluating the therapeutic efficacy of targeting these channels.